The Role Of GAPDH Acetylation And HDAC6 In Liver Metabolism And Type 2 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$635,428.00
Summary
Type 2 diabetes (T2D) is characterised by persistent elevated blood glucose levels. Altered liver metabolism is a key contributor to elevated blood glucose levels in T2D, through uncontrolled synthesis and release of glucose. This project will examine whether regulation of a metabolic enzyme called GAPDH by a process termed acetylation, contributes to normal liver glucose metabolism. This project will also assess whether altered GAPDH acetylation contributes to hyperglycaemia in T2D.